Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Endocrinology ; 158(10): 3526-3539, 2017 10 01.
Artigo em Inglês | MEDLINE | ID: mdl-28977590

RESUMO

Although kisspeptin is the primary stimulator of gonadotropin-releasing hormone secretion and therefore the hypothalamic-pituitary-gonadal axis, recent findings suggest kisspeptin can also regulate additional neuroendocrine processes including release of growth hormone (GH). Here we show that central delivery of kisspeptin causes a robust rise in plasma GH in fasted but not fed sheep. Kisspeptin-induced GH secretion was similar in animals fasted for 24 hours and those fasted for 72 hours, suggesting that the factors involved in kisspeptin-induced GH secretion are responsive to loss of food availability and not the result of severe negative energy balance. Pretreatment with the neuropeptide Y (NPY) Y1 receptor antagonist, BIBO 3304, blocked the effects of kisspeptin-induced GH release, implicating NPY as an intermediary. Kisspeptin treatment induced c-Fos in NPY and GH-releasing hormone (GHRH) cells of the arcuate nucleus. The same kisspeptin treatment resulted in a reduction in c-Fos in somatostatin (SS) cells in the periventricular nucleus. Finally, blockade of systemic ghrelin release or antagonism of the ghrelin receptor eliminated or reduced the ability of kisspeptin to induce GH release, suggesting the presence of ghrelin is required for kisspeptin-induced GH release in fasted animals. Our findings support the hypothesis that during short-term fasting, systemic ghrelin concentrations and NPY expression in the arcuate nucleus rise. This permits kisspeptin activation of NPY cells. In turn, NPY stimulates GHRH cells and inhibits SS cells, resulting in GH release. We propose a mechanism by which kisspeptin conveys reproductive and hormone status onto the somatotropic axis, resulting in alterations in GH release.


Assuntos
Grelina/metabolismo , Hormônio do Crescimento/efeitos dos fármacos , Kisspeptinas/farmacologia , Neuropeptídeo Y/metabolismo , Células Secretoras de Somatostatina/efeitos dos fármacos , Animais , Núcleo Arqueado do Hipotálamo/efeitos dos fármacos , Núcleo Arqueado do Hipotálamo/metabolismo , Arginina/análogos & derivados , Arginina/farmacologia , Atropina/farmacologia , Jejum/metabolismo , Feminino , Imunofluorescência , Hormônio do Crescimento/metabolismo , Hormônio Liberador de Hormônio do Crescimento , Antagonistas Muscarínicos/farmacologia , Oligopeptídeos/farmacologia , Proteínas Proto-Oncogênicas c-fos/efeitos dos fármacos , Proteínas Proto-Oncogênicas c-fos/metabolismo , Receptores de Grelina/antagonistas & inibidores , Receptores de Neuropeptídeo Y/antagonistas & inibidores , Ovinos , Carneiro Doméstico , Células Secretoras de Somatostatina/metabolismo
2.
Neuroendocrinology ; 88(3): 212-5, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18635924

RESUMO

BACKGROUND/AIMS: Growth hormone (GH) is necessary for optimal reproductive efficiency and its secretion is influenced by sex steroids. This study was designed to determine whether kisspeptin-10 (Kp10) could stimulate GH and if gonadal steroids enhance the GH response to Kp10 in cows. METHODS AND RESULTS: Intravenous injection of Kp10 at 100 or 200 pmol/kg body weight with or without treatment with estradiol cypionate and/or progesterone increased luteinizing hormone (p < 0.01) plasma concentrations. Plasma concentrations of GH were increased following Kp10 in cows treated with estradiol cypionate and/or progesterone (p < 0.05) but not in cows treated with Kp10 without gonadal steroids. CONCLUSIONS: These data suggest that reproductive steroids enhance the sensitivity of the somatotropic axis to physiologically relevant doses of Kp10, and support the possibility that Kp10 is an integrator of luteinizing hormone and GH release.


Assuntos
Estradiol/farmacologia , Hormônio do Crescimento/metabolismo , Hormônio Luteinizante/metabolismo , Oligopeptídeos/farmacologia , Progesterona/farmacologia , Animais , Bovinos , Relação Dose-Resposta a Droga , Combinação de Medicamentos , Interações Medicamentosas , Feminino , Injeções Intravenosas , Kisspeptinas , Oligopeptídeos/administração & dosagem , Ovariectomia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA